Login to Your Account



Finish Line in Sight:

SARcode Launches Pivotal Study of SAR 1118 in Dry Eye

By Marie Powers


Thursday, September 15, 2011
Privately held SARcode Bioscience Inc. has enrolled the first patient in OPUS-1, its pivotal Phase III trial of topical SAR 1118 ophthalmic solution. OPUS-1 will study the safety and efficacy of SAR 1118 in the treatment of dry eye.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription